PLYMOUTH, Mich., Sept. 10 /PRNewswire/ -- The primary objective of the Alliance is to improve patient care by accelerating the delivery of biomedical advances to the marketplace.
To celebrate the Alliance, a symposium was held at Boston University on Friday, September 7th with noted speakers from industry, government, entrepreneurs, venture capitalists and the Presidents of both Boston University and Fraunhofer Gesellschaft.
The alliance will take advantage of the two institutions' respective strengths. Advanced biomedical research is being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, resulting in many potential medical innovations. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or created by new, spin-off ventures. The Alliance will leverage the most promising research innovations in labs through Boston University, particularly in its College of Engineering, with the goal of making a significant impact on the way clinical medicine is practiced.
Fraunhofer Gesellschaft is very active in biomedical research. Current activities include plant-based vaccine development, medical imaging, array- based diagnostics, surgical micro-tools development, and other novel devices and instrumentation.
The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1995. Working with BU faculty, students and international interns, the engineers at the Center scale-up basic research into advanced technologies that meet the needs of client companies both locally and globally. The focus of the Center is on the development of next-generation instruments and high precision automation systems for the biotech/biomedical, photonics, and semiconductor industries.
Boston University Professor Andre Sharon, who is also Executive
Director of the Fraunhofer Center for Manufacturin
|SOURCE Fraunhofer USA|
Copyright©2007 PR Newswire.
All rights reserved